| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 82205-95-6 | RA 263 |
≥98% | | 询价 |
| 2 | 15854-12-3 | aPKC-I |
≥98% | | 询价 |
| 3 | 117027-34-6 | Interleukin 1beta |
≥98% | | 询价 |
| 4 | 620-17-7 | 3-Ethylphenol |
≥98% | | 询价 |
| 5 | 86770-68-5 | Azido-PEG5-alcohol |
≥98% | | 询价 |
| 6 | 25552-58-3 | S 1592 |
≥98% | | 询价 |
| 7 | 2182601-81-4 | Azido-PEG8-CH2CO2-NHS |
≥98% | | 询价 |
| 8 | 77-48-5 | 1,3-Dibromo-5,5-dimethylhydantoin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | | Isofistularin-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 209728-15-4 | Hydroxypyruvic acid lithium hydrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 51-17-2 | Benzimidazole |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 13832-70-7 | Stearyl glycyrrhetinate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | | TCMDC-135051 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 2170136-65-7 | GSK-3484862 HCl |
≥98% | | 询价 |
| 15 | | BCN-PEG1-Val-Cit-PABC-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 1881221-47-1 | BCN-PEG4-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | | HS-PEG7-CH2CH2NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | | Carboxyrhodamine 110-PEG4-DBCO |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | | NHS-PEG4-(m-PEG12)3-ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | | Propargyl-PEG12-methane |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 1620461-89-3 | m-PEG12-Br |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | | Thiol-PEG9-alcohol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | | m-PEG-Tresyl(MW 5000) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | | Amino-PEG12-CH2COOH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 1841134-72-2 | BCN-exo-PEG3-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 1258596-39-2 | m-PEG11-Br |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | | Biotin-PEG3-aldehyde |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | | NH2-PEG5-C1-Boc |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | | Mal-PEG-Succinimidyl Valerate(MW 20000) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | | N3-PEG24-Hydrazide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | | IKKγNBD Inhibitory Peptide TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 156792-25-5 | (R)-SCH 42495 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 490-78-8 | 2,5-Dihydroxyacetophenone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 4135-11-9 | Polymyxin B1 |
≥98% | | 询价 |
| 35 | 1571-87-5 | GABAA receptor agent 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 135383-62-9 | N-Boc-Val-Dil-Dap-Doe |
≥98% | | 询价 |
| 37 | 1202764-53-1 | B022 |
≥98% | | 询价 |
| 38 | 72503-80-1 | Sannamycin B |
≥98% | | 询价 |
| 39 | 192329-42-3 | Prinomastat |
≥98% | | 询价 |
| 40 | 59435-08-4 | PYR-5084 |
≥98% | | 询价 |
| 41 | 75272-39-8 | Nemonapride |
≥98% | | 询价 |
| 42 | 93673-82-6 | Hydroxy-PEG1-methyl ester |
≥98% | | 询价 |
| 43 | 135637-46-6 | Atizoram |
≥98% | | 询价 |
| 44 | 1362-42-1 | Absinthin |
≥98% | | 询价 |
| 45 | 154355-75-6 | Atreleuton racemic |
≥98% | | 询价 |
| 46 | 1388658-04-5 | BDM31827 |
≥98% | | 询价 |
| 47 | 74-31-7 | p-Phenylenediamine,N,N'-diphenyl- |
≥98% | | 询价 |
| 48 | 57460-41-0 | Talinolol |
≥98% | | 询价 |
| 49 | 55643-87-3 | ADD-17014 |
≥98% | | 询价 |
| 50 | 55830-67-6 | Rovicurt |
≥98% | | 询价 |
| 51 | 141429-64-3 | SB 201823-A |
≥98% | | 询价 |
| 52 | 800-22-6 | Chloracyzine |
≥98% | | 询价 |
| 53 | 1354812-99-9 | RO5527239 |
≥98% | | 询价 |
| 54 | 92-26-2 | Acridine Yellow |
≥98% | | 询价 |
| 55 | 90-39-1 | (-)-Sparteine |
≥98% | | 询价 |
| 56 | 153804-05-8 | Pratosartan |
≥98% | | 询价 |
| 57 | 3653-50-7 | Acetic acid,dichloro-,2-(2,2-dichloro-N-(p-(methylsulfonyl)benzyl)acetamido)ethyl ester |
≥98% | | 询价 |
| 58 | 747412-64-2 | Luminespib mesylate |
≥98% | | 询价 |
| 59 | 1370540-16-1 | Atelocantel |
≥98% | | 询价 |
| 60 | 2107273-80-1 | N-(m-PEG4)-N'-(Acid-PEG3)-benzothiazole Cy5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com